Mustang Bio and St. Jude enter license agreement

Promising Phase 3 test results give hope for those with the gastrointestinal disorder

Bicoastal startup launches NGS product for pathogen detection

JPS announces major investment and facility expansion, focused on oral solid dose manufacturing

Small-molecule approach blocks autoimmunity in type 1 diabetes

TSRI chemists design ‘miniecosystems’ to test drug function

Molecule blocks neuropathic pain without negative side effects

University of Bristol researcher investigates immune cell defense against microbes

BioAscent and XenoGesis combine core capabilities

Minimally invasive test provides early breast cancer detection

First-in-class EZH2 inhibitor demonstrates safety and efficacy

Rats’ replay of events has implications for AD treatments